Low-Intensity Pulsed Ultrasound Therapy for Patients With Rutherford Stage 4 Peripheral Arterial Disease
Farina Mohamad Yusoff1, Masato Kajikawa2, Takayuki Yamaji1
1Division of Radiation Medical Science, Department of Regenerative Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Abstract:
Patients with severe peripheral artery disease (PAD) require improved vascular treatment options. This report discusses the cases of 2 patients with Rutherford stage 4 PAD who underwent treatment with low-intensity pulsed ultrasound (LIPUS). Patient 1 was a 74-year-old man diagnosed with atherosclerotic PAD. He had undergone multiple endovascular interventions since 2009 and experienced bilateral lower limb rest pain and sleep disturbance. Patient 2 was a 73-year-old woman, also diagnosed with atherosclerotic PAD associated with pseudoxanthoma elasticum. She reported bilateral rest pain in the lower extremities and limitations in activities of daily living. Although both patients had received conventional therapies, their symptoms did not improve. These cases were identified as "no-option" chronic limb-threatening ischemia for consideration of regenerative therapeutic approaches. After 1 month of LIPUS therapy, clinical symptoms improved in both patients. LIPUS therapy may be a safe and effective noninvasive treatment option for improving limb pain in the patients with no-option chronic limb-threatening ischemia.
More Related Videos
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
10:50Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease I: Introduction
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
